Stay updated on Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.

Latest updates to the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small maintenance update to the study details page.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision value was updated from v3.6.3 to v3.6.4, indicating an update to the page’s documentation/template. It represents a version change rather than a change to the study data or visible content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page shows a new revision number (v3.6.3) replacing the previous v3.6.2. This represents a minor metadata update to the Study Details page.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study materials on the page were updated to Revision: v3.6.2, replacing the previous v3.6.0, indicating a newer protocol/document version for the trial.SummaryDifference0.1%

- Check61 days agoChange DetectedRecruitment status shows no current enrollment; new guidance sections were added and header formatting updated, with a new revision tag (v3.6.0).SummaryDifference0.4%

- Check69 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor version update to the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.